(Q30341749)

20 June 2017

1 reference

title

Immunity to influenza: the challenges of protecting an aging population. (English)

1 reference

20 June 2017

1

Jacqueline M Katz

1 reference

20 June 2017

5

Terrence M Tumpey

1 reference

20 June 2017

Suryaprakash Sambhara

series ordinal

6

object named as

Suryaprakash Sambhara

1 reference

20 June 2017

2

Julie Plowden

1 reference

20 June 2017

Mary Renshaw-Hoelscher

series ordinal

3

object named as

Mary Renshaw-Hoelscher

1 reference

20 June 2017

Xiuhua Lu

4

1 reference

20 June 2017

1 January 2004

1 reference

20 June 2017

1 reference

20 June 2017

29

1 reference

20 June 2017

1-3

1 reference

20 June 2017

113-124

1 reference

Pathogenesis of avian influenza A (H5N1) viruses in ferrets

20 June 2017

1 reference

12 December 2020

The impact of influenza epidemics on hospitalizations.

1 reference

12 December 2020

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution

1 reference

12 December 2020

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

12 December 2020

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

1 reference

12 December 2020

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

1 reference

12 December 2020

Human beta-defensins and toll-like receptors in the upper airway.

1 reference

12 December 2020

1 reference

12 December 2020

INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

1 reference

12 December 2020

Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses.

1 reference

12 December 2020

Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses

1 reference

12 December 2020

Avian influenza viruses infecting humans.

1 reference

12 December 2020

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

1 reference

12 December 2020

A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice

1 reference

12 December 2020

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

12 December 2020

The impact of influenza epidemics on mortality: introducing a severity index.

1 reference

12 December 2020

Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.

1 reference

12 December 2020

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

1 reference

12 December 2020

The annual production cycle for influenza vaccine.

1 reference

12 December 2020

Phylogenetic perspectives in innate immunity

1 reference

12 December 2020

The role of immunity in susceptibility to respiratory infection in the aging lung

1 reference

12 December 2020

Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.

1 reference

12 December 2020

Influenza vaccine effectiveness among elderly nursing home residents: a cohort study.

1 reference

12 December 2020

Changes in the aging immune system.

1 reference

12 December 2020

The effect of age on the antigen-presenting mechanism in limiting dilution precursor cell frequency analysis

1 reference

12 December 2020

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

12 December 2020

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

1 reference

12 December 2020

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

12 December 2020

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

12 December 2020

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Immunosenescence and infectious diseases

1 reference

12 December 2020

Cutting edge: impaired Toll-like receptor expression and function in aging

1 reference

12 December 2020

Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans

1 reference

12 December 2020

T cells and aging, January 2002 update.

1 reference

12 December 2020

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden

1 reference

12 December 2020

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

12 December 2020

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

12 December 2020

Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic

1 reference

12 December 2020

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

12 December 2020

CD8 T cells and aging

1 reference

12 December 2020

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

1 reference

12 December 2020

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

12 December 2020

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

1 reference

12 December 2020

The aging immune system: primer and prospectus

1 reference

12 December 2020

Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong

1 reference

12 December 2020

Update: influenza activity--United States and worldwide, 2002-03 season, and composition of the 2003-04 influenza vaccine.

1 reference

12 December 2020

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:29:1-3:113

1 reference

Dimensions Publication ID

20 June 2017

0 references

1 reference